Condition: Hepatocellular Carcinoma · Cirrhosis · Sponsor: Can-Fite BioPharma
This is a clinical trial in patients with advanced hepatocellular carcinoma (HCC) and Child-Pugh Class B7 (CPB7) cirrhosis whose disease has progressed on at least 1st-line therapy. The trial will evaluate the efficacy and safety of namodenoson as compared to placebo.
This description comes directly from the study's public registry record.
Zivit Harpaz · +972 3 924 1114 · Zivit@canfite.co.il
Always discuss trial participation with your own doctor first.
| Site 881 | Dallas, Texas, United States | Not Yet Recruiting |
| 841 University Clinical Centre of Republic of Srpska | Banja Luka, Bosnia and Herzegovina | Not Yet Recruiting |
| 843 University Clinical Hospital Mostar | Mostar, Bosnia and Herzegovina | Not Yet Recruiting |
| 842 University Clinical Centre Sarajevo | Sarajevo, Bosnia and Herzegovina | Not Yet Recruiting |
| 831 Dept of Medical Oncology, Complex Oncology Ctr - Burgas EOOD | Burgas, Bulgaria | Not Yet Recruiting |
| 835 First Department of Medical Oncology, Gastroenterology and Pulmology, Complex Oncology Center - Plovdiv EOOD, Plovdiv | Plovdiv, Bulgaria | Not Yet Recruiting |
| Medical Center Leo Clinic EOOD Plovdiv | Plovdiv, Bulgaria | Not Yet Recruiting |
| 834 Medical Oncology Dept, Univ Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski" EAD, Sofia | Sofia, Bulgaria | Recruiting |
| 518 Rabin Medical Center Beilinson Hospital | Petah Tikva, Israel | Recruiting |
| 872 IMSP Institute of Oncology | Chisinau, Moldova | Recruiting |
| Site 858 | Koszalin, Poland | Not Yet Recruiting |
| Site 852 | Krakow, Poland | Not Yet Recruiting |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05201404